In individual mice in the CpG + anti-OX40 treated group where tumor size continued to increase despite treatment, the primary tumor showed signs of incipient demarcation, however, in two cases, the tumor still proved to be locally invasive. This evidence concerns the gene TNFRSF4 and neoplasm.